Biotagenics Partners with University of Ottawa and CHEO on a $9.1 Million Project with Genome Canada to Develop Therapies for Inflammatory Bowel Disease TORONTO, Jan. 31, 2018 (GLOBE NEWSWIRE) -- Biotagenics Inc., a microbiome-based platform company developing novel therapeutics and diagnostics is the industrial collaborator on a $9.1 million CAD...